
Hangzhou Tigermed Consulting Co., Ltd.
Hinterlegungsschein · US41044T1088 (OTC)
Kein Kurs
Schlusskurs OTC 08.12.2025:
4,00 USD
08.12.2025 21:00
Aktuelle Kurse von Hangzhou Tigermed Consulting Co., Ltd.
| Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
|---|---|---|---|---|---|
UTC |
HNGZY
|
USD
|
08.12.2025 21:00
|
4,00 USD
| 0,00 USD |
Firmenprofil zu Hangzhou Tigermed Consulting Co., Ltd. Hinterlegungsschein
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.
Unternehmensdaten
Name Hangzhou Tigermed Consulting Co., Ltd.
Firma Hangzhou Tigermed Consulting Co., Ltd.
Website
https://www.tigermed.net
Heimatbörse
UTC
ISIN US41044T1088
Wertpapierart Hinterlegungsschein
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Xiaoping Ye D.Phil, EMBA,
Marktkapitalisierung 6 Mrd.
Land China
Währung USD
Mitarbeiter 10,2 T
Adresse F18, Building A – Shengda Science Park, 310051 Hangzhou
IPO Datum 2022-07-11
Ticker Symbole
| Name | Symbol |
|---|---|
| Over The Counter | HNGZY |
Weitere Aktien
Investoren, die Hangzhou Tigermed Consulting Co., Ltd. halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.


